Friday, February 3, 2012

ALL Pro-Life Today: America's Hostility Toward Holiness

 
Pro-Life Today Header
   
Friday, February 3, 2012
 
America's Hostility Toward Holiness 
       

What is it about God's laws and doing God's work that make people so angry and anxious? Through some recent news stories, we can see a hostility that is being bred throughout our country-and it's a scary sight. Read today's commentary for more about this hostility and what is being done to curb it. 

[ Read the full article here. ]

 

                                    

 

CommentaryJB(3)

HEADLINES
wallstreet_homepage
Wall Street Journal opinion piece

"Planned Parenthood's bitter campaign against Komen--aided by left-liberal activists and media--is analogous to a protection racket: Nice charity you've got there. It'd be a shame if anything happened to it. The message to other Planned Parenthood donors is that if they don't play nice and keep coughing up the cash, they'll get the Komen treatment. 

 


eilogo_homepage
After Abortion

After several months' delay, a leading medical journal has published a letter by Elliot Institute director Dr. David Reardon in response to recent ad hominem attacks by abortion advocates attempting to deny a link between abortion and mental health problems in women. The criticism began last fall after the British Journal of Psychiatry (BJP) published a meta-analysis review by Dr. Priscilla Coleman on mental health and abortion. To the dismay of abortion rights advocates, the review showed that women who had abortions were 81 percent more likely to experience mental health problems afterward compared to women who gave birth.


HPV-vaccination_homepage
Life Site News

A researcher who has been a consultant for the manufacturers of the controversial Human Papilloma Virus (HPV) vaccine has conducted a study using money from the one of the companies that purports to show that boys are more likely to contract oral HPV than girls. Dr. Maura L. Gillison, a professor at Ohio State University who has worked as a consultant for Merck and GlaxoSmithKline, was the "principal researcher" for the study, which was itself funded partly by Merck. She is not being coy about the conclusions she wants the public to draw from the results.

 




BrokenPathWSRContact Footer